Exenatide


( Last Updated : August 23, 2011)
Generic Name:
Exenatide
Project Status:
Complete
Therapeutic Area:
Diabetes mellitus, type 2
Manufacturer:
Eli Lilly Canada
Call for patient/clinician input open:
Brand Name:
Byetta
Project Line:
Reimbursement Review
Project Number:
SR0246-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC

Details


Submission Type:
Initial
Indications:
Diabetes mellitus, Type 2
Recommendation Type:
Do not list
Final Recommendation: